BEIGENE, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 153.6 USD | +3.38% |
|
+18.58% | -14.85% |
| 23/04 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
| 23/04 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Chart calendar BeiGene, Ltd.
994b4d66fa41f5a2ca.Md0sXoJWSg1rZlWyy_2FE6r96f8KhUAgKJRQzWJDRAY.B5dbN8RnC2ceCDPcqM3qSeyJ2LFnyhBMHdUAo1srIT5DpXgo8yUBXBteEA~7d5b426c60f35a3becdca9b6e250e57e
Upcoming events on BeiGene, Ltd.
Past events on BeiGene, Ltd.
| 28/03/2024 | Q4 2023 Earnings Release |
| 11/03/2024 07:30 pm | Leerink Partners Global Biopharma Conference |
| 08/03/2024 | Investor Meeting |
| 05/03/2024 08:20 pm | TD Cowen Health Care Conference |
| 26/02/2024 | Q4 2023 Earnings Release |
| 09/01/2024 03:00 am | JPMorgan Healthcare Conference |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 5155 |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 5137 |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 5163 |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 5143 |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 4401 |
| 12/12/2023 06:00 am | American Society of Hematology Meeting - Abstract No - 1011 |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 5144 |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 4655 |
| 11/12/2023 09:30 am | American Society of Hematology Meeting |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 3043 |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 3279 |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No - 3032 |
| 10/12/2023 07:00 am | American Society of Hematology Meeting - Abstract No - 1682 |
| 10/12/2023 07:00 am | American Society of Hematology Meeting - Abstract No - 2337 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 428 445 -3.82% | 309 337 -8.35% | 1 176 1 198 -1.84% | 1 416 1 420 -0.32% | 2 459 2 414 1.87% | 3 083 |
|
EBITDA Million USD | Released Forecast Spread | -941 -685 -37.4% | -1 626 -1 453 -11.9% | -1 392 -1 201 -15.88% | -1 723 -1 678 -2.69% | -1 120 -1 105 -1.38% | -802 |
|
EBIT Million USD | Released Forecast Spread | -960 -752 -27.72% | -1 658 -1 525 -8.69% | -1 439 -1 239 -16.11% | -1 790 -1 751 -2.23% | -1 208 -1 161 -3.99% | -934 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -944 -740 -27.53% | -1 618 -1 480 -9.35% | -1 439 -1 253 -14.77% | -1 961 -1 853 -5.82% | -826 -903 8.51% | -882 |
|
Net income Million USD | Released Forecast Spread | -949 -750 -26.52% | -1 597 -1 467 -8.88% | -1 413 -1 223 -15.55% | -2 004 -1 832 -9.4% | -882 -911 3.23% | -892 |
|
EPS USD | Released Forecast Spread | -15,8 -14,0 -13.18% | -19,1 -17,8 -7.75% | -15,2 -10,0 -52.22% | -19,4 -15,0 -29.66% | -8,45 -8,56 1.3% | -8,55 |
| Announcement Date | 02/03/20 | 25/02/21 | 25/02/22 | 27/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 214 215 -0.28% | 420 386 8.92% | 307 260 17.76% | 342 311 9.81% | 388 377 2.7% | 380 388 -2.08% | 606 723 -16.13% | 448 449 -0.36% | 595 515 15.5% | 1 043 946 10.32% | 781 578 35.12% | 634 638 -0.61% | 673 | 753 | 830 | 843 | 708 |
|
EBITDA Million USD | Released Forecast Spread | -559 -114 -391.04% | -427 -247 -72.78% | -424 -310 -36.86% | -422 -355 -18.83% | -451 -442 -1.91% | -351 -346 -1.55% | -112 -232 51.55% | -565 -304 -86.18% | -406 | -203 | -199 | -151 | -115 | ||||
|
EBIT Million USD | Released Forecast Spread | -572 -463 -23.48% | -443 -456 2.88% | -439 -397 -10.61% | -438 -391 -12.08% | -469 -472 0.67% | -907 -1 086 16.48% | -371 -373 0.58% | -319 -393 18.97% | -690 -781 11.66% | -134 -345 61.22% | -589 -364 -61.67% | -347 | -238 | -236 | -217 | -150 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -587 -473 -24.19% | -421 -494 14.79% | -558 -446 -24.94% | -551 -377 -46.08% | -431 -457 5.77% | -982 -1 075 8.63% | -337 -374 10.01% | -367 -379 3.17% | -704 -729 3.37% | 229 -365 162.87% | -351 -441 20.54% | -259 | -234 | -233 | -198 | ||
|
Net income Million USD | Released Forecast Spread | -586 -486 -20.55% | -1 000 -925 -8.05% | -434 -519 16.3% | -571 -370 -54.36% | -558 -396 -40.84% | -445 -456 2.24% | -998 -1 105 9.67% | -348 -403 13.62% | -381 -381 0.04% | -730 -752 2.92% | 215 -376 157.31% | -368 -431 14.81% | -265 | -244 | -238 | -207 | |
|
EPS USD | Released Forecast Spread | -6,16 -4,99 -23.36% | -4,24 -5,32 20.35% | -5,56 -4,11 -35.12% | -5,39 -3,85 -40.04% | -4,29 -4,19 -2.47% | -3,34 -3,82 12.45% | -3,64 -3,53 -2.98% | 2,01 -3,28 161.25% | -3,48 -4,03 13.68% | -2,89 | -2,43 | -2,13 | -1,71 | ||||
| Announcement Date | 25/02/22 | 25/02/22 | 05/05/22 | 04/08/22 | 09/11/22 | 27/02/23 | 27/02/23 | 04/05/23 | 02/08/23 | 02/08/23 | 09/11/23 | 26/02/24 | - | - | - | - | - |
More events
Past sector events for BeiGene, Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BGNE Stock
- Calendar BeiGene, Ltd.
